Danaher Continues Life Sciences Business Expansion with US$9.6 B Aldevron Acquisition
By Debadrita Paul
Pharma Deals Review: Vol 2021 Issue 7 (Table of Contents)
Published: 23 Jul-2021
DOI: 10.3833/pdr.v2021.i7.2627 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Danaher has agreed to acquire Aldevron, a manufacturer of plasmid DNA, mRNA, and recombinant proteins for projects ranging from early-stage research to clinical trials and commercial applications...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS